The term 'fake news' can be used to describe stories that are made up to deceive, stories containing partial truths, stories that are speculative and not based on evidence and stories that we simply do not agree with. The definition specifically depends on what we want to read.
Generally, science has been circumspect and the incidence of "fake" science has been small, but, unfortunately, not zero. Unlike the internet and computergenerated "bots" that radically accelerate fake news and disinformation, science limits the spread with peer review.
Peer review and impact factor serve to guarantee a minimum level of scrutiny and, in an era of presumptive and fake news, it is inevitable that science needs to be more vigilant.
Authors, reviewers and editors do a remarkable job of promoting evidence-based science. Submitted manuscripts are reviewed, first by the author and institution for originating factual information and, then, the manuscript is evaluated as a credible, unbiased, timely and ethical scientific treatise. Expert reviewers then place their arguments to the Editor who uses counsel to make an informed decision. Unfortunately, in spite of such rigorous conduct, there is and will be an inevitable minority which escape. However, this is much less than non-scientific news.
I am pleased that Perfusion, as evidenced by the steady rise in impact factor, continues to be credible and my gratitude goes to authors, reviewers and experts who give their opinion for giving us a balanced scientific policy.
Gerard Myers starts this issue with an invited commentary on a need to review old opinions with a consideration of air in intravenous lines. Moscarelli et al. add to our knowledge base with a meta-analysis, again re-enforcing real news as, if any of the manuscripts included in the meta-analysis was fake, it would have influenced the statistical outcome. Moscarelli advises us that the value of adding sub-valvular procedures for chronic ischaemic mitral regurgitation surgery would be erroneous.
Another scientific reality check is the multidisciplinary approach which Antonitsis and colleagues put forward as a multi-disciplinary, perioperative strategy for attaining "more physiologic" cardiac surgery.
Again, a reality check, it is difficult to sway a multidisciplinary team in a biased fashion influencing decision.
Stammers evaluates the effectiveness of acute normolvolaemic haemodilution and autologous prime on intraoperative blood management during cardiac surgery as does Issitt, undertaking an appraisal of lipid microemboli inducing acute kidney injury during cardiopulmonary bypass.
Ichikawa interprets changes in heparin dose-response slope during cardiac surgery as possibly resulting in inaccuracy in predicting heparin bolus dose requirement to achieve the target ACT.
Sistino provides us with an important update of 2017 regarding the epidemiology of cardiovascular disease in the United States as an implication for the perfusion profession.
I am pleased that Perfusion continues to attract such important submissions and am grateful for the support of my whole team in conducting Perfusion. 
